Announcement
26 Sep 2023
In September 2023, US BARDA awarded a contract to ModeX Therapeutics to support the development of a monoclonal antibody against COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
26 Sep 2023
Revocation date:
No revocation date
Updated: 26 Sep 2023
State aid, unspecified
In force
On 26 September 2023, the Biomedical Advanced Research and Development Authority (BARDA) of the United States announced awarding ModeX Therapeutics a contract to support the development of a monocl...
Sign in to see more
Related State Acts
26 Sep 2024
United States of America: BARDA awards ModeX Therapeutics USD 35 million to support the development of multispecific antibodies against COVID-19
10 Apr 2023
United States of America: US Administration launches Project Next Gen initiative to fight against all COVID variants and future Coronaviruses
Threads
See all
This state act is not part of any Thread yet.